{{'Search' | translate}}
 

Nylon mesh cell strainer 40 micron

Company: BD
Catalog#: 352340
Bio-protocol()
Company-protocol()
Other protocol()

Modeling NOTCH1 driven T-cell Acute Lymphoblastic Leukemia in Mice
Author:
Date:
2020-05-20
[Abstract]   T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy that arises from transformation of T-cell primed hematopoietic progenitors. Although T-ALL is a heterogenous and molecularly complex disease, more than 65% of T-ALL patients carry activating mutations in the NOTCH1 gene. The majority of T-ALL–associated NOTCH1 mutations either disrupt the negative regulatory region, allowing signal activation in the absence of ligand binding, or result in truncation of the C-terminal PEST domain involved in the termination of NOTCH1 signaling by proteasomal degradation. To date, retroviral transduction models have relied heavily on the overexpression of aggressively truncated variants of NOTCH1 (such as ICN1 or ΔE-NOTCH1), which result in ... [摘要]  [摘要 ] T细胞急性淋巴细胞白血病(T-ALL)是一种侵袭性血液恶性肿瘤,其起源于T细胞引发的造血祖细胞的转化。尽管T-ALL是一种异质且分子复杂的疾病,但超过65%的T-ALL患者在NOTCH1 基因中带有激活突变。大多数与T-ALL相关的NOTCH1 突变要么破坏负调控区,允许在没有配体结合的情况下激活信号,要么导致蛋白酶体降解终止NOTCH1信号终止所涉及的C末端PEST域被截短。迄今为止,逆转录病毒转导模型在很大程度上依赖于侵袭性截短的变种的过度表达。 NOTCH1 (例如ICN1或ΔE-NOTCH1)可导致信号传导的超生理水平,并且在人类T-ALL中很少见。当前方案描述了小鼠骨髓分离,造血干细胞和祖细胞(HSC)富集,然后逆转录病毒转导的致癌突变体形式的NOTCH1受体(NOTCH1-L1601P-ΔP)的方法,该方法与获功能突变最常见于患者样品中。组成型活性NOTCH1的这种强制表达的标志是胸腺外未成熟T细胞发育的瞬时波,此波在致癌性转化为T-ALL之前。此外,该方法通过允许白血病细胞与微环境之间的串扰来模拟体内白血病的转化和进展,这是基于细胞系的体外研究无法解释的一个方面。因此,HSC转导和移植模型更真实地概括了人类疾病的发展,为进一步的体内和离体功能研究提供了高度全面和通用的工具。

[背景 ] ...

Phagocytosis Assay for α-Synuclein Fibril Uptake by Mouse Primary Microglia
Author:
Date:
2018-09-05
[Abstract]  Microglia are professional phagocytes in the brain and deficiency in their phagocytic activity plays an important role in Parkinson’s disease. This protocol mainly describes the phagocytosis assay for uptake of α-synuclein preformed fibrils, a pathologic form of α-synuclein, by primary microglia. [摘要]  小胶质细胞是大脑中的专业吞噬细胞,其吞噬活性的缺乏在帕金森病中起重要作用。 该方案主要描述了通过原代小胶质细胞摄取α-突触核蛋白预先形成的原纤维(α-突触核蛋白的病理形式)的吞噬作用测定。

【背景】作为大脑的免疫细胞,小胶质细胞在中枢神经系统中起着关键作用。在生理状态下,小胶质细胞不断探索周围环境并参与突触修剪。小胶质细胞可被任何类型的病理事件或脑内稳态的变化激活(Wolf et al。,2017)。激活后,小胶质细胞经历形态学变化,增殖,分泌炎性细胞因子,迁移至病变部位,吞噬病原体,病细胞,碎片,甚至细胞外蛋白质聚集体(Kettenmann et al。,2011; Fu et al。,2014)。 α-突触核蛋白是神经元中的丰富蛋白质,并且是帕金森病中称为路易体和路易神经突的神经元内包涵体的主要成分(Luk 等人,,2012)。最近的研究表明α-突触核蛋白经历细胞间扩散,小胶质细胞是α-突触核蛋白的主要清除剂,它可能承担来自神经元的α-突触核蛋白的负担(Wolf et al。,2017 )。在这里,我们描述了使用人α-突触核蛋白单体产生预先形成的原纤维并通过小胶质细胞吞噬作用测量α-突触核蛋白预先形成的原纤维的摄取的方案(Du et al。,2017)。

Investigating Neural Stem Cell and Glioma Stem Cell Self-renewal Potential Using Extreme Limiting Dilution Analysis (ELDA)
Author:
Date:
2018-09-05
[Abstract]  Glioma stem cells (GSC) grown as neurospheres exhibit similar characteristics to neural stem cells (NSC) grown as neurospheres, including the ability to self-renew and differentiate. GSCs are thought to play a role in cancer initiation and progression. Self-renewal potential of GSCs is thought to reflect many characteristics associated with malignancy, including tumor recurrence following cytotoxic therapy due to their proliferative dormancy and capacity to allow for the development of resistant tumor cell sub-clones due to mutations acquired during their differentiation. Here, we demonstrate that using extreme limiting dilution analysis (ELDA), subtle differences in the frequency of sphere-forming potential between PI3K-mutant oncogenic NSCs and non-oncogenic NSCs can be measured, in ... [摘要]  作为神经球生长的神经胶质干细胞(GSC)表现出与作为神经球生长的神经干细胞(NSC)相似的特征,包括自我更新和分化的能力。 GSC被认为在癌症的发生和发展中起作用。 GSC的自我更新潜力被认为反映了与恶性肿瘤相关的许多特征,包括细胞毒性治疗后的肿瘤复发,这是由于它们的增殖性休眠和由于在其分化期间获得的突变而允许产生抗性肿瘤细胞亚克隆的能力。在这里,我们证明使用极限稀释分析(ELDA),可以测量PI3K-突变致癌NSCs和非致癌NSCs之间的球形成潜力频率的细微差异体外。我们进一步展示了ELDA如何在强制分化之前和之后用于细胞,以放大突变体和对照NSCs之间的球形成潜力的固有差异。最终,ELDA利用单个或少数种子干细胞自我更新,分裂和形成神经球的能力差异。重要的是,该测定还允许在不同条件下在遗传上不同的细胞之间或相同细胞之间进行比较,其中可以测试靶特异性药物或其他新型癌症干细胞疗法的影响。

【背景】胶质母细胞瘤(GBM)是最常见的脑癌之一,预后极差(Kaye和Morokoff,2014)。 ...

Comments